Loading company…
Modulus Therapeutics develops cell therapy candidates for solid tumors.
Founded in 2020 and based in Washington, Modulus Therapeutics develops early cell product candidates for further testing by cellular therapy companies. Its products are intended to treat solid tumors. Founders Bryce Daines and Max Darnell raised USD 3.5 million in Seed funding in July 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in